Back to Country Data Country Overview:
Country Overview:
Eswatini
Last Updated: 19 June 2025
Drug Registration Status
Approved
Pending
Not
Approved
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Approved 2022 †
2022 †
Dapivirine Vaginal Ring (DVR) — Pop Council
Approved 2022
2022
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved
Oral PrEP TDF/xTC* - generic
Not Approved
Oral PrEP F/TAF — Gilead
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)
Additional Product Approvals Information for Eswatini
† This country uses an alternate pathway for regulatory approval for these products. This country relies on approval from the South African Health Products Regulatory Authority (SAHPRA) and pre-qualification from the World Health Organization (WHO) to authorize an Import License.
Research, Demonstration and Implementation
Oral PrEP
5 Completed Projects
Dapivirine Vaginal Ring
2 Planned/Ongoing Projects
Injectable PrEP
1 Planned/Ongoing Projects